Abstract:Background: Coronavirus disease-2019 (COVID-19) epidemic is spreading globally. Sex differences in the severity and mortality of COVID-19 emerged. This study aims to describe the impact of sex on outcomes in COVOD-19 with a special focus on the effect of estrogen. Methods: We performed a retrospective cohort study which included 413 patients (230 males and 183 females) with COVID-19 from three designated hospitals in China with a follow up time from January 31, 2020, to April 17, 2020. Women over 55 were considered as postmenopausal patients according to the previous epidemiological data from China. The interaction between age and sex on in-hospital mortality was determined through Cox regression analysis. In addition, multivariate Cox regression models were performed to explore risk factors associated with in-hospital mortality of COVID-19. Results: Age and sex had significant interaction for the in-hospital mortality ( P < 0.001). Multivariate Cox regression showed that age (HR 1.041, 95% CI 1.009–1.073, P = 0.012), male sex (HR 2.033, 95% CI 1.007–2.098, P = 0.010), the interaction between age and sex (HR 1.118, 95% CI 1.003–1.232, P = 0.018), and comorbidities (HR 9.845, 95% CI 2.280–42.520, P = 0.002) were independently associated with in-hospital mortality of COVID-19 patients. In this multicentre study, female experienced a lower fatality for COVID-19 than male (4.4 vs. 10.0%, P = 0.031). Interestingly, stratification by age group revealed no difference in-hospital mortality was noted in women under 55 compared with women over 55 (3.8 vs. 5.2%, P = 0.144), as well as in women under 55 compared with the same age men (3.8 vs. 4.0%, P = 0.918). However, there was significantly difference in women over 55 with men of the same age group (5.2 vs. 21.0%, P = 0.007). Compared with male patients, female patients had higher lymphocyte ( P < 0.001) and high-density lipoprotein ( P < 0.001), lower high sensitive c reaction protein level ( P < 0.001), and lower incidence rate of acute cardiac injury (6.6 vs. 13.5%, P = 0.022). Conclusion: Male sex is an independent risk factor for COVID-19 in-hospital mortality. Although female mortality in COVID-19 is lower than male, it might not be directly related to the effect of estrogen. Further study is warranted to identify the sex difference in COVID-19 and mechanisms involved.

Aromatase, testosterone, TMPRSS2: determinants of COVID-19 severity

Insights from Immunomics and Metabolomics on the Associations between Prostatic Diseases and COVID-19

Sex-specific Causal Effects of Serum Sex Hormones on COVID-19 Susceptibility and Severity: Evidence from the UK Biobank and COVID-19 Host Genetics Initiative

CYP19A1 mediates severe SARS-CoV-2 disease outcome in males

COVID-19 and Sex Differences: Mechanisms and Biomarkers

Sex Differences in Viral Entry Protein Expression and Host Transcript Responses to SARS-CoV-2

Evaluation of Sex‐related Hormones and Semen Characteristics in Reproductive‐aged Male COVID‐19 Patients

Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes

Sex Hormones in COVID-19 Severity: the Quest for Evidence and Influence Mechanisms.

Serum Level of Testosterone Predicts Disease Severity of Male COVID-19 Patients and is Related to T-Cell Immune Modulation by Transcriptome Analysis

Sex differences in immune responses that underlie COVID-19 disease outcomes

Male Predisposition to Severe COVID-19: Review of Evidence and Potential Therapeutic Prospects

Sex Differences in Severity and Mortality Among Patients With COVID-19: Evidence from Pooled Literature Analysis and Insights from Integrated Bioinformatic Analysis

The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors

(070) Androgen Status in Men and Risk Of COVID-19 Complications: An Analysis of United States Claims Data

Suppression of Androgen Receptor (AR)-ACE2/TMPRSS2 Axis by AR Antagonists May Be Therapeutically Beneficial for Male COVID-19 Patients

Serum Testosterone Is Associated With the Severity of COVID-19

Sex-Disaggregated Data on Clinical Characteristics and Outcomes of Hospitalized Patients With COVID-19: A Retrospective Study

Sex-based clinical and immunological differences in COVID-19

Sex Differences on Clinical Characteristics, Severity, and Mortality in Adult Patients With COVID-19: A Multicentre Retrospective Study

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities